Amgen Inc. & Subsidiaries

CourtUnited States Tax Court
DecidedApril 4, 2024
Docket15631-22
StatusUnpublished

This text of Amgen Inc. & Subsidiaries (Amgen Inc. & Subsidiaries) is published on Counsel Stack Legal Research, covering United States Tax Court primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Amgen Inc. & Subsidiaries, (tax 2024).

Opinion

United States Tax Court

T.C. Memo. 2024-38

AMGEN INC. & SUBSIDIARIES, Petitioner

v.

COMMISSIONER OF INTERNAL REVENUE, Respondent

__________

Docket Nos. 16017-21, 15631-22. Filed April 4, 2024.

Andrew P. Crousore and Rajiv Madan, for petitioner.

Jill A. Frisch, Cathy A. Goodson, Usha Ravi, Julie P. Gasper, Kathryn F. Patterson, John M. Altman, and Elizabeth P. Flores, for respondent.

MEMORANDUM OPINION

GREAVES, Judge: The primary issue in these consolidated cases is the Commissioner’s allocation of income under section 482 between Amgen Inc. and Amgen Manufacturing Limited. 1 Currently before the Court is respondent’s June 12, 2023, Motion for Partial Summary Judgment contending that the Internal Revenue Service (IRS) complied with the requirements of section 6751(b)(1) by securing timely supervisory approval for all penalties included in the notice of deficiency, dated April 15, 2022, related to tax years 2013 through 2015. 2 For the reasons set forth below, we will grant respondent’s motion.

1 Unless otherwise indicated, statutory references are to the Internal Revenue

Code, Title 26 U.S.C., in effect at all relevant times, and Rule references are to the Tax Court Rules of Practice and Procedure. 2 Respondent issued a prior notice of deficiency, dated June 29, 2021, to

petitioner relating to tax years 2010 through 2012 but did not determine penalties for

Served 04/04/24 2

[*2] Background

The following facts are derived from the pleadings, the parties’ motion papers, and the exhibits and declarations attached thereto. They are stated solely for purposes of deciding respondent’s motion and not as findings of fact in these cases. See Sundstrand Corp. v. Commissioner, 98 T.C. 518, 520 (1992), aff’d, 17 F.3d 965 (7th Cir. 1994).

Petitioner is the parent corporation of a multinational group of consolidated corporations and affiliated companies, specializing in biologic therapeutics. Petitioner had its principal place of business in California when it filed the petitions. Absent stipulation to the contrary, appeal of these cases would lie to the U.S. Court of Appeals for the Ninth Circuit. See § 7482(b)(1)(B).

The IRS has routinely selected petitioner’s returns for examination. As relevant to the pending motion, the IRS audited petitioner’s 2010 through 2012 federal tax returns. On November 29, 2017, at the close of this audit, the IRS prepared and issued to petitioner a memorandum entitled “Notice of Failure to Correctly Report Financial Statements for Transfer Pricing Analysis” (exam memorandum). In relevant part, the exam memorandum stated:

The purpose of this memorandum is to inform the Taxpayer that the transfer pricing method for Amgen USA during the tax years ended December 31, 2010 to 2012 may preclude the Taxpayer from having a reasonable cause for an underpayment attributable to a net section 482 [adjustment].

The IRS began its examination of the returns for tax years 2013 through 2015 approximately four months after it issued the exam memorandum. As relevant to this motion, the IRS had two teams working on the issues of (1) increasing petitioner’s income to clearly reflect income and prevent the evasion of taxes under section 482 (transfer pricing adjustments) and (2) increasing petitioner’s income on account of payments received in connection with healthcare reform fees imposed by section 9008 of the Patient Protection and Affordable Care Act, Pub. L. No. 111-148, 124 Stat. 119, 859 (2010) (HCR fee

these years. On December 19, 2022, we granted a joint Motion to Consolidate Docket No. 16017-21, related to tax years 2010 through 2012, with Docket No. 15631-22, related to tax years 2013 through 2015. The motion at issue relates exclusively to the case at Docket No. 15631-22. 3

[*3] adjustments). The IRS Examination Division issue manager for the transfer pricing adjustments was Supervisory Revenue Agent (SRA) Andy Soemardi, and the IRS Examination Division issue manager for the HCR fee adjustments was SRA Gregory Horwitz.

During the examination revenue agents working on the transfer pricing adjustments recommended the assertion of accuracy-related penalties for gross valuation misstatements and substantial understatements of income tax. See § 6662(a), (b)(2), (3), (d), (h). Both penalties were approved in writing on February 27, 2020, by SRA Soemardi. One of the revenue agents also recommended the assertion of accuracy-related penalties for substantial valuation misstatements. See § 6662(a), (b)(3), (e). This penalty was approved in writing by SRA Soemardi on May 8, 2020. As for the team working on the HCR fee adjustment issue, a revenue agent recommended the assertion of accuracy-related penalties for substantial understatements of income tax. See § 6662(a), (b)(2), (d). This penalty was approved in writing by SRA Horwitz on March 10, 2020. Collectively, this Opinion will refer to penalties determined during the examination as examination penalties.

On May 8, 2020, the IRS issued the 30-day package to petitioner. Petitioner requested that the case be transferred to the Independent Office of Appeals (Appeals Office) for review. The Appeals Office reviewed the file and sent a draft of the notice of deficiency to the Office of Chief Counsel for review. An attorney with the Office of Chief Counsel recommended alternative accuracy-related penalties for negligence or disregard of rules or regulations regarding the transfer pricing adjustment and HCR fee adjustments. See § 6662(a), (b)(1), (c). On February 22, 2022, the attorney’s immediate supervisor, Associate Area Counsel Shirley Mao, provided written approval for the alternative penalties, and the recommendation was sent back to the Appeals Office. Collectively, this Opinion will refer to penalties determined by the Office of Chief Counsel as Chief Counsel penalties.

The Appeals officer adopted this recommendation and asserted the Chief Counsel penalties. On February 28, 2022, the Appeals officer’s immediate supervisor approved the penalties in writing. After this approval, the IRS issued the notice of deficiency on April 15, 2022. The notice increased petitioner’s income related to the transfer pricing adjustments and HCR fees adjustments. As a primary theory, the IRS determined that petitioner was liable for accuracy-related penalties for gross valuation misstatements related to the transfer pricing adjustments and substantial understatements related to the HCR fee 4

[*4] adjustments. The IRS made further alternative determinations that petitioner was liable for the remaining examination and Chief Counsel penalties.

Petitioner timely filed petitions for redetermination of the deficiencies. On June 12, 2023, respondent filed the motion now under consideration. On July 14, 2023, petitioner filed an Opposition to Motion for Partial Summary Judgment, arguing that the exam memorandum was the first formal communication regarding the penalties. Because the penalties were not approved in writing before the IRS issued the exam memorandum, petitioner argues that under our precedent the supervisory approval was not timely. On August 9, 2023, with leave of the Court, respondent filed a Reply to Opposition to Motion for Partial Summary Judgment.

Discussion

I. Summary Judgment

The purpose of summary judgment is to expedite litigation and avoid costly, unnecessary, and time-consuming trials. See FPL Grp., Inc. & Subs. v. Commissioner, 116 T.C. 73, 74 (2001). We may grant summary judgment where there is no genuine dispute of material fact and a decision may be rendered as a matter of law. See Rule 121(a)(2); Elec. Arts, Inc. v. Commissioner, 118 T.C. 226, 238 (2002).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Bond v. Commissioner
100 T.C. No. 4 (U.S. Tax Court, 1993)
FPL Group, Inc. v. Commissioner
116 T.C. No. 7 (U.S. Tax Court, 2001)
Elec. Arts, Inc. v. Comm'r
118 T.C. No. 13 (U.S. Tax Court, 2002)
NT, Inc. v. Comm'r
126 T.C. No. 8 (U.S. Tax Court, 2006)
Sundstrand Corp. v. Commissioner
98 T.C. No. 36 (U.S. Tax Court, 1992)
Laidlaw's Harley Davidson Sale v. Cir
29 F.4th 1066 (Ninth Circuit, 2022)

Cite This Page — Counsel Stack

Bluebook (online)
Amgen Inc. & Subsidiaries, Counsel Stack Legal Research, https://law.counselstack.com/opinion/amgen-inc-subsidiaries-tax-2024.